Temiverine

Drug Profile

Temiverine

Alternative Names: NS 21; Urespan

Latest Information Update: 08 Sep 2009

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Nippon Shinyaku
  • Class Phenylacetates
  • Mechanism of Action Calcium channel antagonists; Cholinergic receptor antagonists; Muscarinic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Overactive bladder

Most Recent Events

  • 08 Sep 2009 Discontinued - Preregistration for Overactive bladder in Japan (PO)
  • 08 May 2006 This compound is still in active development for Overactive bladder
  • 21 Nov 2000 A clinical study has been added to the pharmacokinetics and adverse events sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top